본문 바로가기
KERD
논문KCI 등재

신생아 혈전색전증

Neonatal Thromboembolic Disorders

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

The etiology of thrombosis is multifactorial and involves the interaction of inherited and acquired risk factors. Many neonatal thromboembolic disorders are iatrogenic and their incidence is likely to increase as advancements are made in neonatal care. Among pediatric populations, neonates have the highest risk for thrombosis secondary to the unique developmental hemostatic system, inherited prothrombotic disorders, and perinatal clinical conditions. Central venous and arterial catheters present the greatest risk for developing thromboembolisms in neonates. Both venous and arterial thromboses have been reported in a variety of anatomic locations. Prompt identification and appropriate management of thromboembolisms is critical for avoiding life-threatening complications. To date, few data are currently available regarding the contribution of inherited and acquired prothrombotic disorders in the pathogenesis of neonatal thromboembolism. In particular, a lack of information about neonatal thromboembolism in Korea has inhibited the development of appropriate guidelines for diagnosing thromboembolisms in neonates. An overview of the current knowledge about the role of inherited and acquired risk factors for neonatal thromboembolism in the West and a detailed description of common neonatal thromboembolic diseases is reviewed.

Abstract

The etiology of thrombosis is multifactorial and involves the interaction of inherited and acquired risk factors. Many neonatal thromboembolic disorders are iatrogenic and their incidence is likely to increase as advancements are made in neonatal care. Among pediatric populations, neonates have the highest risk for thrombosis secondary to the unique developmental hemostatic system, inherited prothrombotic disorders, and perinatal clinical conditions. Central venous and arterial catheters present the greatest risk for developing thromboembolisms in neonates. Both venous and arterial thromboses have been reported in a variety of anatomic locations. Prompt identification and appropriate management of thromboembolisms is critical for avoiding life-threatening complications. To date, few data are currently available regarding the contribution of inherited and acquired prothrombotic disorders in the pathogenesis of neonatal thromboembolism. In particular, a lack of information about neonatal thromboembolism in Korea has inhibited the development of appropriate guidelines for diagnosing thromboembolisms in neonates. An overview of the current knowledge about the role of inherited and acquired risk factors for neonatal thromboembolism in the West and a detailed description of common neonatal thromboembolic diseases is reviewed.

참고문헌 (55)

  1. Schmidt B, "Neonatal thrombosis: report of a prospective Canadian and international registry", Pediatrics, 96, pp.939~943 (1995)
  2. Andrew M, "Developmental hemostasis: relevance to hemostatic problems during childhood", Semin Thromb Hemost, 21, pp.341~356 (1995)
  3. van Ommen CH, "Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands", J Pediatr, 139, pp.676~681 (2001)
  4. Saxonhouse MA, "The evaluation and management of neonatal coagulation disorders", Semin Perinatol, 33, pp.52~65 (2009)
  5. Nowak-Gottl U, "Neonatal symptomatic thromboembolism in Germany: two year survey", Arch Dis Child Fetal Neonatal Ed, 76, pp.F163~F167 (1997)
  6. Thornburg C, "Neonatal thromboembolic emergencies", Semin Fetal Neonatal Med, 11, pp.198~206 (2006)
  7. Manco-Johnson MJ, "Development of hemostasis in the fetus", Thromb Res, 115(1), pp.55~63 (2005)
  8. Saxonhouse MA, "The evaluation and management of postnatal thromboses", J Perinatol, 29, pp.467~478 (2009)
  9. Boo NY, "Risk factors associated with umbilical vascular catheter-associated thrombosis in newborn infants", J Paediatr Child Health, 35, pp.460~465 (1999)
  10. Saracco P, "Management and investigation of neonatal thromboembolic events: genetic and acquired risk factors", Thromb Res, 123, pp.805~809 (2009)
  11. Nowak-Gottl U, "Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors", Blood, 97, pp.858~862 (2001)
  12. Nowak-Gottl U, "Factor V Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis in childhood: a prospective study", J Pediatr, 131, pp.608~612 (1997)
  13. Koster T, "Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study", Lancet, 342, pp.1503~1506 (1993)
  14. Dahlback B, "Resistance to activated protein C, the FV:Q506 allele, and venous thrombosis", Ann Hematol, 72, pp.166~176 (1996)
  15. Zoller B, "Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis", Annu Rev Med, 48, pp.45~58 (1997)
  16. Schneppenheim R, "Thrombosis in infants and children", Hematology Am Soc Hematol Educ Program, pp.86~96 (2006)
  17. Kim TW, "Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis", J Korean Med Sci, 13, pp.587~590 (1998)
  18. Poort SR, "A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis", Blood, 88, pp.3698~3703 (1996)
  19. Junker R, "Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia", Arterioscler Thromb Vasc Biol, 19, pp.2568~2572 (1999)
  20. Monagle P, "Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)", Chest, 133, pp.887s~968s (2008)
  21. Bucciarelli P, "Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study", Arterioscler Thromb Vasc Biol, 19, pp.1026~1033 (1999)
  22. Eldibany MM, "Hyperhomocysteinemia and thrombosis: an overview", Arch Pathol Lab Med, 131, pp.872~884 (2007)
  23. Rook JL, "Pediatric stroke and methylenetetrahydrofolate reductase polymorphisms: an examination of C677T and A1298C mutations", J Pediatr Hematol Oncol, 27, pp.590~593 (2005)
  24. Nowak-Göttl U, "Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood", Blood, 94, pp.3678~3682 (1999)
  25. Nowak-Göttl U, "Increased lipoprotein (a) is an important risk factor for venous thromboembolism in childhood", Circulation, 100, pp.743~748 (1999)
  26. Revel-Vilk S, "Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease", J Thromb Haemost, 1, pp.915~921 (2003)
  27. Boffa MC, "Infant perinatal thrombosis and antiphospholipid antibodies: a review", Lupus, 16, pp.634~641 (2007)
  28. Manco-Johnson MJ, "Laboratory testing for thrombophilia in pediatric patients. On behalf of the Subcommittee for Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis (ISTH)", Thromb Haemost, 88, pp.155~156 (2002)
  29. Nowak-Göttl U, "Thromboembolic diseases in neonates and children", Pathophysiol Haemost Thromb, 33, pp.269~274 (2003)
  30. Turebylu R, "Genetic prothrombotic mutations are common in neonates but are not associated with umbilical catheter-associated thrombosis", J Perinatol, 27, pp.490~495 (2007)
  31. Schmidt B, "Thrombotic disease in newborn infants", Clin Perinatol, 11, pp.461~488 (1984)
  32. Khilnani P, "Double lumen umbilical venous catheters in critically ill neonates: a randomized prospective study", Crit Care Med, 19, pp.1348~1351 (1991)
  33. Tanke RB, "Thrombus detection on central venous catheters in the neonatal intensive care unit", Angiology, 45, pp.477~480 (1994)
  34. O’Grady NP, "Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S", Pediatrics, 110, pp.e51~ (2002)
  35. Butler-O’Hara M, "A randomized trial comparing long-term and short-term use of umbilical venous catheters in premature infants with birth weights of less than 1251 grams", Pediatrics, 118, pp.e25~e35 (2006)
  36. Narang S, "Risk factors for umbilical venous catheter-associated thrombosis in very low birth weight infants", Pediatr Blood Cancer, 52, pp.75~79 (2009)
  37. Greenway A, "Neonatal thrombosis and its treatment", Blood Rev, 18, pp.75~84 (2004)
  38. Barnes C, "Post-thrombotic syndrome", Arch Dis Child, 86, pp.212~214 (2002)
  39. Barrington KJ, "Umbilical artery catheters in the newborn: effects of position of the catheter tip", Cochrane Database Syst Rev, pp.CD000505~ (2000)
  40. Barrington KJ, "Umbilical artery catheters in the newborn: effects of catheter design (end vs. side hole)", Cochrane Database Syst Rev, pp.CD000508~ (2000)
  41. Barrington KJ, "Umbilical artery catheters in the newborn: effects of heparin", Cochrane Database Syst Rev, pp.CD000507~ (2000)
  42. Lau KK, "Neonatal renal vein thrombosis: review of the English-language literature between 1992 and 2006", Pediatrics, 120, pp.e1278~e1284 (2007)
  43. Kosch A, "Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up", Blood, 104, pp.1356~1360 (2004)
  44. Marks SD, "Neonatal renal venous thrombosis: clinical outcomes and prevalence of prothrombotic disorders", J Pediatr, 146, pp.811~816 (2005)
  45. Winyard PJ, "Perinatal renal venous thrombosis: presenting renal length predicts outcome", Arch Dis Child Fetal Neonatal Ed, 91, pp.F273~F278 (2006)
  46. Kim JH, "Does umbilical vein catheterization lead to portal venous thrombosis", Prospective US evaluation in 100 neonates. Radiology, 219, pp.645~650 (2001)
  47. Morag I, "Portal vein thrombosis in the neonate: risk factors, course, and outcome", J Pediatr, 148, pp.735~739 (2006)
  48. Yadav S, "Do umbilical vein catheterization and sepsis lead to portal vein thrombosis? A prospective, clinical, and sonographic evaluation", J Pediatr Gastroenterol Nutr, 17, pp.392~396 (1993)
  49. Alvarez F, "Portal obstruction in children. I. Cinical investigation and hemorrhage risk", J Pediatr, 103, pp.696~702 (1983)
  50. DeVeber G, "Cerebral sinovenous thrombosis in children", N Engl J Med, 345, pp.417~423 (2001)
  51. Wasay M, "Cerebral venous sinus thrombosis in children: a multicenter cohort from the United States", J Child Neurol, 23, pp.26~31 (2008)
  52. Ramenghi LA, "Neonatal cerebral sinovenous thrombosis", Semin Fetal Neonatal Med, 14, pp.278~283 (2009)
  53. Wu YW, "Intraventricular hemorrhage in term neonates caused by sinovenous thrombosis", Ann Neurol, 54, pp.123~126 (2003)
  54. Fitzgerald KC, "Cerebral sinovenous thrombosis in the neonate", Arch Neurol, 63, pp.405~409 (2006)
  55. Berfelo FJ, "Neonatal cerebral sinovenous thrombosis from symptom to outcome", Stroke, 41, pp.1382~1388 (2010)

관련 논문AI추천

이 간행물의 다른 논문 (22건)